Bradbury Daniel's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Sep 6, 2023
- Accession no.
- 0001447362-23-000136
- Filed
- Sep 6, 2023
- Trade date
- Sep 1, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $36.1K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bradbury DanielCIK 0001236397 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2023 | Common Stock | SSaleDisposed | −1,082 | $20.04F2 | −$21,683.28 | 101,305 | Indirect | |
| Sep 1, 2023 | Common Stock | SSaleDisposed | −360 | $20.04F2 | −$7,214.4 | 65,037 | Indirect | |
| Sep 1, 2023 | Common Stock | SSaleDisposed | −360 | $20.04F2 | −$7,214.4 | 65,062 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $20.00 to $20.11, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.